- Analysis
- Barani Krishnan
- 32
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
Metrics to compare | 028300 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship028300PeersSector | |
---|---|---|---|---|
P/E Ratio | −55.6x | −4.4x | −0.6x | |
PEG Ratio | 0.69 | 0.01 | 0.00 | |
Price/Book | 19.7x | 2.1x | 2.6x | |
Price / LTM Sales | 199.0x | 4.4x | 3.1x | |
Upside (Analyst Target) | - | 48.7% | 51.7% | |
Fair Value Upside | Unlock | 11.3% | 7.5% | Unlock |